English
Tiếng Việt
(en)An oil base skin care composition including squalane and a method for treating skin are disclosed. The method includes the step of individually displaying a plurality of visual skin guides to a consumer. Each of the visual skin guides includes a plurality of visual representations of a categorical skin condition. Each of the visual representations correspond to a severity score for the categorical skin condition on the visual skin guide. The method further includes correlating the severity score for each of the categorical skin conditions for each of the visual skin guides to the consumer's current skin condition. At least two target skin conditions from the plurality of categorical skin conditions are determined in response to the severity scores for each of the categorical skin conditions. At least one booster containing at least one active ingredient is correlated for treating each target skin condition.
1.ApplicationNumber: US-201615251740-A
1.PublishNumber: US-2017281492-A1
2.Date Publish: 20171005
3.Inventor: DERSH JUSTIN
GENESKY Geoffrey
GOLDBERG JODI
ROBERT VALERIE
FU Victoria
ELMASRY CAROL
4.Inventor Harmonized: DERSH JUSTIN(US)
GENESKY Geoffrey(US)
GOLDBERG JODI(US)
ROBERT VALERIE(US)
FU Victoria(US)
ELMASRY CAROL(US)
5.Country: US
6.Claims:
(en)An oil base skin care composition including squalane and a method for treating skin are disclosed. The method includes the step of individually displaying a plurality of visual skin guides to a consumer. Each of the visual skin guides includes a plurality of visual representations of a categorical skin condition. Each of the visual representations correspond to a severity score for the categorical skin condition on the visual skin guide. The method further includes correlating the severity score for each of the categorical skin conditions for each of the visual skin guides to the consumer's current skin condition. At least two target skin conditions from the plurality of categorical skin conditions are determined in response to the severity scores for each of the categorical skin conditions. At least one booster containing at least one active ingredient is correlated for treating each target skin condition.
7.Description:
(en)CROSS-REFERENCE TO RELATED APPLICATIONS
This patent application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/316,334 filed on Mar. 31, 2016 and entitled “Method and Composition for Treating Skin Conditions”, the disclosure of which is hereby incorporated by reference herein in its entirety and made part of the present U.S. utility patent application for all purposes.
FIELD OF THE INVENTION
The present invention is directed to a skin care composition and a method for treating skin conditions. More specifically, the present invention is directed to a skin care composition that has targeted active ingredients for treating target skin conditions and methods for creating customized skin care compositions.
BACKGROUND OF THE INVENTION
Personalized skin care systems are desirable for consumers to provide a skin care composition that meets the skin care needs of the individual consumer.
Known personalized product lines include MaCrèmeSurMesure by Dr. Pierre Ricaud, Codage Paris, Customized TCM by Yue Sai, and prescription personalized serums (Re-Plasty) by Helena Rubinstein.
Helena Rubinstein uses a skinprofiler, a cutaneous analysis device that generates quantitative data to analyze a variety of skin attributes to diagnose consumers in-store and provide them with a personalized prescription product consisting of one universal serum base and single dose of concentrate. Helena Rubenstein products only consist of one single dose of concentrate containing actives that seek to address all skincare needs. In addition, the Helena Rubenstein product is a serum (aqueous based) product with water-soluble actives. The Helena Rubinstein skinprofiler measures elasticity, pigmentation, and texture of the skin and prescribes concentrate based on these results only.
Codage Paris has a custom-made skincare product line. Consumers use a website diagnostic tool in which they answer 23 questions that were developed by different specialists (including dermatologists, pharmacists, and nutritionists). Based on the results, Codage selects and formulates a composition in their existing line and sends consumers a final product within a week. The Codage Paris system does not include a base composition with personalized boosters. Codage Paris is a serum (aqueous based) product with water soluble actives. A diagnostic tool utilized for Codage is an online survey which automatically ‘prescribes’ a final product based on provided answers. The Codage Product provides a final pre-prepared formula for the consumer, which is sent directly from store to consumer, wherein no mixing is required.
MaCrèmeSurMesure by Dr. Pierre Ricaud similarly uses an online diagnostic tool in which consumers are given a questionnaire on their current skin and lifestyle. Based on the answers they provide, the website provides them with a cream base and combination of three active concentrates. Each “concentrate” for the MaCrèmeSurMesure only contains a single active ingredient. Typical “concentrates” for the MaCrèmeSurMesure products consist solely of pure extracts (100% active extract of chufa tubers, for example) and do not provide formulations. The MaCrèmeSurMesure product is aqueous based (water based moisturizing gel texture) and booster “concentrates” are water soluble extracts in aqueous form. The consumer is sent a kit with their products and mixes at home with a small mixing tool provided, which is not easily co-soluble. MaCrèmeSurMesure uses an online questionnaire to diagnose consumer.
Yue Sai is a Customized TCM Beauty Solution Ultimate Refining Serum that includes in-store formulations in China. The tailoring of the formulations were limited and included only aqueous based compositions.
There remains a need to provide an effective, targeted anhydrous oil based skin care composition and method for treating skin that is customized to specific, individual customer target skin compositions and is readily dispersible.
BRIEF SUMMARY OF THE INVENTION
In an exemplary embodiment, a method for treating skin including the step of individually displaying a plurality of visual skin guides to a consumer. Each of the visual skin guides includes a plurality of visual representations of a categorical skin condition. Each of the visual representations correspond to a severity score for the categorical skin condition on the visual skin guide. The method further includes correlating the severity score for each of the categorical skin conditions for each of the visual skin guides to the consumer's current skin condition. At least two target skin conditions from the plurality of categorical skin conditions are determined in response to the severity scores for each of the categorical skin conditions. At least one booster containing at least one active ingredient for treating is correlated to each target skin condition In addition, an oil base formulation including squalane is provided. The booster compositions and oil base formulations are individually packaged and the booster compositions are readily dispersible in the oil base formulation.
In another exemplary embodiment, a skin care system having a base oil composition including squalane and a plurality of booster compositions readily dispersible into the base oil composition and comprising corresponding active ingredients. The corresponding active ingredients being ingredients that correspond to treatment skin conditions determined by a consumer. The system includes packaging comprising separate containers for each of the booster compositions and the base oil composition.
The present disclosure is also directed to a method for cosmetic treatment of skin by applying the above-disclosed composition onto a surface of the skin.
Other features and advantages of the present invention will be apparent from the following more detailed description of the preferred embodiment which illustrates, by way of example, the principles of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a method, according to an embodiment of the present disclosure.
FIG. 2 is a visual skin guide, according to an embodiment of the present disclosure.
FIG. 3 is a skin care system, according to an embodiment of the present disclosure.
Wherever possible, the same reference numbers will be used throughout the drawings to represent the same parts.
DETAILED DESCRIPTION OF THE INVENTION
All numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term “about”, unless otherwise indicated.
“Keratinous tissue,” as used herein, includes, but is not limited to, skin, hair, and nails.
“Homogenous” means having the visual appearance of being substantially uniform throughout, i.e., visually appears as a single phase.
The method and system, according to the present disclosure, includes a method wherein a comprehensive assisted in-store target skin condition diagnosis practice with a targeted and efficacious product that is mixed at the consumer's home in order to use. An assisted or unassisted skin diagnosis/questionnaire, using visual aids, is completed to provide targeted skin care system to address the individual customer's needs. In one embodiment, consumers are shown representative photos of common skin conditions, wherein the consumers view the visual aids and correlate the visual aids with their individual skin care needs. Based on the correlation to the target skin conditions, the consumers get a customized skin care system having a base oil composition and two selected active booster compositions, which the consumer mixes at home.
Method
FIG. 1 shows a method 100 , according to the present disclosure. Method 100 includes individually displaying a plurality of visual skin guides 200 to a consumer (step 101 ). FIG. 2 shows an exemplary visual skin guide for skin wrinkles. Although FIG. 2 shows an example of visual skin guide, the present invention is not so limited and may include other types of visual displays or other categorical skin conditions. Other suitable types of visual displays include, but are not limited to, books, brochures and pamphlets including, but not limited to, pictures and/or description of skin condition and scale, clinical pictures, and photos taken with instrumental devices. The pictures and/or photos may include representations of skin conditions for panelists of different ethnicities and skin types. The visual display will correspond to the varying ethnicities and skin types. A selection of a specific visual display is made to consumer's ethnicity and/or skin types. The visual skin guide 200 is a device including visual representations 201 , including, but not limited to, images, pictorial representations or similar visual devices that provide information regarding categorical skin conditions. In one embodiment, as shown in FIG. 2 , each of the visual skin guides includes a plurality of visual representations of a categorical skin condition. In this embodiment, each of the visual representations correspond to a severity score 203 for the categorical skin condition on the visual skin guide. The method includes determining the severity score 203 from the visual skin guides 200 , (step 103 ). For example, the visual representations may include photographs showing a particular category of skin condition of the categorical skin conditions including, but not limited to, skin brightness, skin lines/wrinkles, visibility of pores, skin texture, skin redness, skin firmness, skin tone evenness with a score that corresponds to severity. The severity score 203 may be a numerical value, grade value or any other suitable scoring that permits the comparison of the categorical skin conditions. In one embodiment, the visual skin guide 200 includes four photographs of a particular skin condition scored numerically, for example, from 1 to 3 or from 1 to 4 or from 1 to 5 or from 1 to 10 or from 1 to 20 or from 1 to 100.
The method 100 further includes correlating the severity score 203 for each of the categorical skin conditions for each of the visual skin guides to the consumer's current skin condition. The correlating includes comparing the severity scores of each of the categorical skin conditions and determining a plurality of target skin conditions for treatment (step 105 ). The correlation may include a comparison of the numerical value, grade or other value indicator for the severity of the skin condition to determine which skin conditions are suitable for treatment. In other embodiments, the correlation may include a consultation with a skin care professional, who may assist the consumer in determining the severity score or may assist in comparing the severity score in determining the target skin conditions. At least two target skin conditions are determined from the plurality of categorical skin conditions in response to the severity scores for each of the categorical skin conditions with or without consultation with a skin care professional.
In the embodiment, wherein consultation from a skin care professional is utilized, consultation time of about 20 minutes with consumer has been determined to be beneficial. The skin care consultant may provide direction relating to the consumer's current regimen, skin type, skin concerns and lifestyle. To assess top skin concerns, diagnostic tools which may include, but is not limited to, a combination of a special prescription card (ranking of concerns) and reference pictures (skin atlas) are utilized.
As shown in FIG. 1 , after the target skin conditions are determined, boosters with at least one active ingredient are correlated for each of the target skin conditions (step 107 ). The boosters that are selected for the target skin conditions are selected based upon active ingredients that provide improvement in the target skin condition. For example, in one embodiment, the boosters containing active ingredients correlating to target conditions are selected as compositions that are capable of treating conditions selected from skin brightness, skin wrinkles, visibility of pores, skin texture, skin redness, skin firmness, and skin tone evenness. After the boosters are selected, a kit including the selected booster and base oil are created or assembled (step 109 ).
Brightening Booster Composition
In one embodiment, the target skin condition determined for treatment is skin brightness. The active ingredient corresponding to skin brightness includes one or more actives that provide improvement to skin brightness. In one embodiment, at least 25% or from about 25% to about 40% or from about 28% to about 35%, about 26%, about 30%, about 34%, or about 38%, by weight of the brightening booster active for skin brightness is included in the brightening booster composition. For example, in one embodiment, the actives corresponding to the skin brightness include one or more of ascorbyl tetraisopalmitate, phenylethyl resorcinol, arbutin, eperua falcata bark extract, ceramides, punica granatum fruit extract, citrus aurantium dulcis (orange) peel essential oil, rapeseed oil, cassia alata leaf extract, purple rice extract, other components that provide improvement to skin brightness, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to skin brightness include greater than about 27% or from about 28% to about 34% or from about 29% to 31%, about 28%, about 30%, about 32%, or about 34% by weight of the brightening booster composition ascorbyl tetraisopalmitate, and greater than about 1% or from about 1% to about 5% or from about 2% to 3.5%, about 1%, about 2%, about 3%, or about 4%, by weight of the brightening booster composition phenylethyl resorcinol.
Pore Minimizing Booster Composition
In one embodiment, the target skin condition determined for treatment is visibility of pores. The active ingredient corresponding to skin brightness includes one or more actives that provide improvement to visibility of pores. In one embodiment, at least 25% or from about 25% to about 40% or from about 28% to about 35%, about 25%, about 28%, about 31%, about 33%, about 36% or about 39% by weight of the pore minimizing active for pore minimizing is included in the brightening booster composition. For example, in one embodiment, the actives corresponding to the visibility of pores include one or more of ascorbyl tetraisopalmitate, salicylic acid, crithimum maritimum extract, totarol, ulkenia amoeboidea oil, other components that provide improvement to visibility of pores, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to visibility of pores include greater than about 27% or from about 28% to about 34% or from about 29% to 31%, about 28%, about 30%, about 32%, or about 34% by weight of the pore minimizing booster composition ascorbyl tetraisopalmitate, greater than about 0.5% or from about 0.75% to about 2.0% or from about 1.0% to 1.5%, about 1.1%, about 1.2%, about 1.3%, or about 1.4% by weight of the pore minimizing booster composition salicylic acid, and greater than about 0.25% or from about 0.05% to about 0.25% or from about 0.07% to 0.15% or about 0.10%, about 0.11%, about 0.13%, or about 0.14% by weight of the pore minimizing booster composition about crithimum maritimum extract, based upon the weight of the booster composition.
Texture Refining Booster Composition
In one embodiment, the target skin condition determined for treatment is texture refining. The active ingredient corresponding to texture refining includes one or more actives that provide improvement to skin texture. In one embodiment, the active ingredients in the booster composition corresponding to texture refining include greater than about 7.5% or from about 10% to about 20% or from about 11% to about 14%, about 10%, about 12%, about 14%, about 16%, about 18%, or about 20% by weight of the texture refining booster composition. For example, in one embodiment, the actives corresponding to skin texture include one or more of glyceryl linoleate (and) glyceryl oleate (and) glyceryl linolenate, punica granatum fruit extract, shea butter, rice bran oil, safflower oil, phospholipids, panax ginseng root extract, other components that provide improvement to skin texture, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to skin texture include greater than about 7.5% or from about 10% to about 20% or from about 11% to about 14%, about 10%, about 12%, about 14%, about 16%, about 18% or about 20% by weight of the texture refining booster composition glyceryl linoleate (and) glyceryl oleate (and) glyceryl linolenate.
Visible Redness Booster Composition
In one embodiment, the target skin condition determined for treatment is visible redness. The active ingredient corresponding to visible redness includes one or more actives that provide improvement to the skin redness. In one embodiment, the active ingredients in the booster composition corresponding to visible redness include greater than about 7.5% or from about 10% to about 20% or from about 11% to 14%, about 10%, about 12%, about 14%, about 16%, about 18% or about 20% by weight of the visible redness booster composition. For example, in one embodiment, the actives corresponding to the skin texture include one or more of helianthus annuus (sunflower) seed oil unsaponifiables, melissa officinalis leaf oil, zingiber officinale (ginger) root oil, anthemis nobilis flower oil, other components that provide improvement to skin redness, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to skin redness include at least one active ingredient corresponding to skin redness include greater than about 7.5% or from about 10% to about 20% or from about 11% to 14%, about 12%, about 14%, about 16%, about 18%, or about 20% by weight of the visible redness booster composition helianthus annuus (sunflower) seed oil unsaponifiables, based upon the weight of the booster composition.
Wrinkle Reducing Booster Composition
In one embodiment, the target skin condition determined for treatment is skin wrinkles. The active ingredient corresponding to wrinkle reducing includes one or more actives that provide improvement to the skin wrinkles. For example, in one embodiment, the actives corresponding to the skin wrinkles include at least one active ingredient selected from the group consisting of retinol, retinyl palmitate, punica granatum fruit extract, pelargonium graveolens flower oil, melissa officinalis leaf oil, zingiber officinale (ginger) root oil, theobroma cacao (cocoa) extract, purple rice extract, phytosphingosine, cinnamic acid, other components that provide improvement to skin wrinkles, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to wrinkle reduction include greater than about 0.5% or from about 1.0% to about 3.0% or from about 1.5% to 2.0%, about 1.0%, about 1.5%, about 2.0%, about 2.5%, or about 3.0% by weight of the wrinkle reducing booster composition. In one embodiment, the active ingredients in the booster composition corresponding to skin wrinkles include at least one active ingredient corresponding to skin wrinkles include greater than about 0.25% or from about 0.5% to about 1.5% or from about 0.75% to 1.00% about 0.5%, about 0.7%, about 0.9%, about 1.1%, about 1.3% or about 1.5% by weight of the wrinkle reducing booster composition retinol, and greater than about 0.25% or from about 0.5% to about 1.5% or from about 0.75% to 1.00%, about 0.5%, about 0.7%, about 0.9%, about 1.1%, about 1.3% or about 1.5%, by weight of the wrinkle reducing booster composition retinyl palmitate, based upon the weight of the booster composition.
Booster Additives
The booster compositions noted above may further include additional additives. For example, the booster compositions may include essential oils, Vitamin E, emollients or other ingredients for skin enhancement, solubilization or other beneficial or efficacious purpose. In one embodiment, for example, the booster compositions may include squalane for moisturization, capryloyl salicylic acid for cell turnover and/or botanical oils for skin conditioning.
Base Oil Composition
In addition to the plurality of booster compositions, a base oil composition is also provided. Each of the base oil and the booster compositions are formulated with an anhydrous oil composition, wherein the composition is preferably devoid of water and water based components. The anhydrous composition is appropriate for custom, tailored skin care kit as the compositions contain no water and therefore less prone to microbiological contamination. The anhydrous oil based base oil composition and booster compositions provide a high affinity to skin due to the oil base and permit beneficial mixing of the desired actives. The base oil includes components suitable for providing skin care benefits, such as moisturization, protection of skin barrier, or other skin benefit. Squalane or botanical oils, for example, in a concentration comprising greater than about 20% or greater than about 25% or greater than about 30% or greater than about 35%, by weight of total composition. In one embodiment, the base oil composition comprises squalane, botanical oil, hexyldecanol, and tocopherol, octyldodecanol, dicaprylyl ether, zea mays (corn) oil, passiflora edulis seed oil, and/or oryza sativa (rice) bran oil. Booster composition and base oil composition are formulated cosoluble for ease of use.
Cosolubilization
The booster compositions described above include the active ingredients noted specifically for the categorical skin condition (e.g., skin brightness, skin wrinkles, visibility of pores, skin texture, and/or skin redness). In addition, the compositions cosolubilize to permit easy dispersion of the booster composition into the base oil composition. In addition to easy dispersion, the system according to the present disclosure ensures rapid homogeneity of the final products after combination of booster and base components by the consumer. In each of the booster compositions, at least one of the ingredients in the base oil composition are included in the booster compositions. For example, in one embodiment, squalane is included in each of the booster compositions. In one particularly advantageous embodiment, greater than about 20% or greater than about 25% or greater than about 30% or greater than about 35%, by weight of total composition squalane is included in each of the booster compositions. Visual assessment may be conducted to ensure cosolubility. For example, cosolubility may be determined by visual determination of incompatibility, immicible components, precipitates or other visual indicators indicating a lack of cosolubility.
Auxiliaries
The composition, according to the invention, may comprise at least one dyestuff chosen especially from pigments, nacres, liposoluble dyes, and mixtures thereof.
The term “pigments” should be understood as meaning white or colored, mineral or organic particles of any shape, which are insoluble in the physiological medium and are intended to color the composition.
The term “nacres” should be understood as meaning iridescent particles of any shape, especially produced by certain molluscs in their shell or else synthesized.
The term “dyes” should be understood as meaning generally organic compounds that are soluble in fatty substances, such as oils.
The pigments may be white or colored, and mineral and/or organic. Among the mineral pigments that may be mentioned are titanium dioxides, optionally surface-treated, zirconium oxide and cerium oxide, and also zinc oxide, iron oxide (black, yellow or red) or chromium oxide, manganese violet, ultramarine blue, chromium hydrate and ferric blue and metal powders, such as aluminum powder or copper powder.
An example that may be mentioned is micronized titanium dioxide powder surface-treated with a silica/aluminum hydroxide/alginic acid mixture, sold under the name MT-100AQ.
Among the organic pigments that may be mentioned are carbon black, pigments of D&C type and lakes based on cochineal carmine or on barium, strontium, calcium or aluminum.
The nacreous pigments may be chosen from white nacreous pigments, such as mica coated with titanium or with bismuth oxychloride, colored nacreous pigments, such as titanium mica coated with iron oxides, titanium mica coated especially with ferric blue or with chromium oxide, titanium mica coated with an organic pigment of the abovementioned type, and also nacreous pigments based on bismuth oxychloride.
The liposoluble dyes are, for example, Sudan red, D&C Red No. 17, D&C Green No. 6, β-carotene, soybean oil, Sudan brown, D&C Yellow No. 11, D&C Violet No. 2, D&C Orange No. 5, quinoline yellow, annatto and bromo acids.
The dyestuffs may be present in an amount of from about 0.01% to about 30%, by weight, such as from about 0.1% to about 20%, by weight, such as from about 0.5% to about 15%, by weight, and most preferably from about 0.5% to about 5%, by weight, relative to the total weight of the composition.
In a known manner, the composition of the invention may also contain adjuvants that are common in cosmetics, such as humectants, preserving agents, antioxidants, complexing agents, solvents, fragrances, bactericides, odor absorbers, vitamins, moisturizers, self-tanning compounds and anti-wrinkle active agents. The amounts of these various adjuvants are those conventionally used in the field under consideration, for example, from 0.01% to 20% of the total weight of the composition. Depending on their nature, these adjuvants may be introduced into the fatty phase and/or into lipid vesicles. In one embodiment, the additives or adjuvants would be added to the booster formulations to functionalize them for specific targeted treatments/needs.
The composition of the present disclosure may also contain cosmetically acceptable additives or adjuvants as well as cosmetic or dermatologic active agents. Representative additives and adjuvants include, for example, oil-soluble or oil-miscible solvents or co-solvents. Suitable examples of additives and adjuvants include, but are not limited to, fatty alcohols, fatty amides, alkylene carbonates, glycols, lower alcohols (e.g. ethanol, propanediol), dispersion enhancing agents, polymers, thickening agents, stabilizers, moisturizers, humectants, colorants, fillers, chelating agents, antioxidants (e.g. BHT, tocopherol), essential oils, fragrances, dyes, neutralizing or pH-adjusting agents (e.g., citric acid, triethylamine (TEA) and sodium hydroxide), preservatives, bactericides, conditioning or softening agents (e.g., panthenol and allantoin), extracts, such as botanical extracts, or any other ingredient commonly used in cosmetics for this type of application. Additives and adjuvants may be present in the compositions in amounts generally ranging from about 0.01% to about 10%, by weight. Examples of cosmetic active agents or dermatological active agents include free-radical scavengers, vitamins (e.g., Vitamin E and derivatives thereof), anti-elastase and anti-collagenase agents, peptides, fatty acid derivatives, steroids, trace elements, extracts of algae and of planktons, enzymes and coenzymes, flavonoids and ceramides, hydroxy acids and mixtures thereof, and enhancing agents. These ingredients may be soluble or dispersible in oil phase(s) that is/are present in the composition.
Of course, a person skilled in the art will take care to choose this or these optional additional compounds so that the advantageous properties intrinsically attached to the composition, in accordance with the invention, are not, or not substantially, detrimentally affected by the envisaged addition or additions.
Needless to say, a person skilled in the art will take care to select this or of these optional additional compound(s), and/or the amount thereof, such that the advantageous properties of the composition, according to the invention, are not, or are not substantially, adversely affected by the envisaged addition.
Packaging
As shown in FIG. 1 , after the booster compositions are determined and the base oil composition is provided, the booster compositions and oil base formulations are individually assembled into a kit or system including the selected boosters and base oil (step 109 ). FIG. 3 shows an exemplary configuration of a skin care system 300 , according to an embodiment of the present disclosure. The packaging and system are configured to permit mixing of the booster compositions 303 and the base oil composition 301 at home with simple agitation. For example, the base oil composition 301 includes sufficient space in the packaging to receive the booster composition 303 and to permit agitation, such as by shaking the container. Ophthalmic tip tubes, for example, may help consumer mix boosters into primary dropper containing base. The co-solubilized booster composition 303 readily disperses into the base oil composition to form a treatment composition.
The following examples are intended to further illustrate the present invention. They are not intended to limit the invention in any way. Unless otherwise indicated, all parts are by weight.
EXAMPLES
Example 1
TABLE 1
INGREDIENT
Base Oil
EMOLLIENTS
44
SQUALANE
35
BOTANICAL OILS
20
ANTIOXIDANTS
1
Total
100
TABLE 2
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
0.6
0.6
0.6
1.2
ACID
PHENYLETHYL
3
RESORCINOL
ESSENTIAL OILS
0.7
1.2
1.2
0.6
EMOLLIENTS
32.2
9.2
8
30.2
32
SQUALANE
35
35
35
35
35
BOTANICAL OILS
20
20
20
20
20
SALICYLIC ACID
1.2
CRITHMUM MARITIMUM
3
EXTRACT*
HELIANTHUS ANNUUS
12
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
12
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
1
1
1
1
1
RETINYL PALMITATE (and)
1.5
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
9
ASCORBYL
30
30
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Example 1 shows various range of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 1 shows effective composition of base oil. TABLE 2 shows effective composition of boosters. The inventive examples in TABLE 1 and 2 show various ranges of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
Comparative Example 1
TABLE 3
INGREDIENT
Base Oil
EMOLLIENTS
89.9
SQUALANE
5
BOTANICAL OILS
5
ANTIOXIDANTS
0.1
Total
100
TABLE 4
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
5
5
5
10
ACID
PHENYLETHYL
0.1
RESORCINOL
ESSENTIAL OILS
0.1
0.1
0.1
0.1
EMOLLIENTS
84.6
79.7
54.8
78.8
88.9
SQUALANE
5
5
5
5
5
BOTANICAL OILS
5
5
5
5
5
SALICYLIC ACID
5
CRITHMUM MARITIMUM
10
EXTRACT*
HELIANTHUS ANNUUS
1
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
1
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
0.1
0.1
0.1
0.1
0.1
RETINYL PALMITATE (and)
0.1
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
0.1
ASCORBYL
5
5
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Comparative Example 1 shows various range of compositions that would not be effective For example, deficiencies of this comparative example include compositions with active levels that are beyond the solubility limit of the formulation as well as active levels that are so low that they do not provide efficacious results to the consumer.
Example 2
TABLE 5
INGREDIENT
Base Oil
EMOLLIENTS
48
SQUALANE
25
BOTANICAL OILS
25
ANTIOXIDANTS
2
Total
100
TABLE 6
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
1
1
1
1.5
ACID
PHENYLETHYL
5
RESORCINOL
ESSENTIAL OILS
1.1
1
0.9
0.5
EMOLLIENTS
30
13
10.1
26
28
SQUALANE
25
25
25
25
25
BOTANICAL OILS
25
25
25
25
25
SALICYLIC ACID
0.75
CRITHMUM MARITIMUM
1.25
EXTRACT*
HELIANTHUS ANNUUS
20
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
20
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
2
2
2
2
2
RETINYL PALMITATE (and)
0.9
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
15
ASCORBYL
28
34
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Example 2 shows various range of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 5 shows effective composition of base oil. TABLE 6 shows effective composition of boosters. The inventive examples in TABLE 5 and 6 show various ranges of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
Example 3
TABLE 7
INGREDIENT
Base Oil
EMOLLIENTS
49
SQUALANE
20
BOTANICAL OILS
30
ANTIOXIDANTS
1
Total
100
TABLE 8
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
0.5
0.5
0.5
1
ACID
PHENYLETHYL
1
RESORCINOL
ESSENTIAL OILS
0.5
0.8
1.4
0.9
EMOLLIENTS
40.3
12.7
10.85
37.1
39
SQUALANE
20
20
20
20
20
BOTANICAL OILS
30
30
30
30
30
SALICYLIC ACID
2
CRITHMUM MARITIMUM
6.25
EXTRACT*
HELIANTHUS ANNUUS
10
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
10
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
1
1
1
1
1
RETINYL PALMITATE (and)
2.7
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
5
ASCORBYL
34
28
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Example 3 shows various range of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 7 shows effective composition of base oil. TABLE 8 shows effective composition of boosters. The inventive examples in TABLE 7 and 8 show various ranges of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 9
INCI US
Loading (wt %)
Salicylic Acid
3%
5%*
10%*
15%*
Caprylyl Salicylic Acid
3%
5%*
10%*
15%*
Phenylethyl Resorcinol
5%
10%
15%
—
Ascorbyl Tetraisopalmitate
40%
50%
60%
—
Crithmum Martimum Extract (4% Active)
5%
10%*
15%*
—
Retinol (10% Active)
10%
20%
30%
—
Retinyl Palmitate (and) Helianthus Annuus Seed
5%
10%
20%
—
Oil (55% Active)
Glyceryl Linoleate (and) Glyceryl Oleate (and)
15%
20%
40%
—
Glyceryl Linolenate
*Insoluble
TABLE 9 shows solubility of active ingredients in base oil composition.
TABLE 10
Base with
Base with
Wrinkle
Base with
Visible Redness
Reducing
Pore and
Neutralizing
and
Texture
Booster and
Brightening
Booster
Texture
Booster from
from
Booster
INGREDIENT
Example 1
Example 2
from Example 3
CAPRYLOYL
0.2
0.42
0.17
SALICYLIC ACID
PHENYLETHYL
0.5
RESORCINOL
ESSENTIAL OILS
0.32
0.23
0.15
EMOLLIENTS
36.23
38.00
45.34
SQUALANE
35
25
20
BOTANICAL OILS
20
25
30
SALICYLIC ACID
0.13
CRITHMUM
0.21
MARITIMUM
EXTRACT*
HELIANTHUS
1.67
ANNUUS
(SUNFLOWER) SEED
OIL
UNSAPONIFIABLES
GLYCERYL
3.34
1.67
LINOLEATE (and)
GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
1
2
1
RETINYL PALMITATE
0.25
(and) HELIANTHUS
ANNUUS
(SUNFLOWER) SEED
OIL**
RETINOL***
1.50
ASCORBYL
5.00
5.67
TETRAISOPALMITATE
Total
100
100
TABLE 10 shows an exemplary chart of booster+base combinations.
Summary of Clinical/Consumer testing:
An instrumental evaluation of the effectiveness in improving skin hydration and maintaining skin barrier function was carried out on the base oil formulation. Under the conditions of the study, the oil elicited statistically significant improvements in skin barrier function when compared to the baseline and statistically significant improvements in skin hydration when compared to the baseline.
TABLE 11
Skin Strengthening Concentrate-Clinical Instrumental Testing
Claim
Assessment
Improvement in skin barrier function (TEWL)
X
Improvement in skin hydration
X
“X” indicates statistically significant improvement at later time point when compared to baseline (p < 0.05)
Clinical evaluations were conducted on representative formulas containing each booster; formula compositions consisted of the base oil and the booster complex in the ratio 5:1. Various skin attributes of the representative formulas were evaluated via by an expert grader both initially and at later time points. Under the conditions of the study, results show a statistically significant improvement in attributes of the skin over time vs. baseline for all booster representative formulas.
TABLE 12
Attribute
Assessment
Brightening
Improvement in skin radiance/brightness/
X
Complex
luminosity
Improvement in skin tone evenness
X
Improvement in overall appearance of skin
X
quality
Wrinkle Reducing
Improvement in appearance of Fine Lines
X
Complex
Improvement in appearance of Wrinkles
X
Improvement in Overall Appearance of Skin
X
Quality
Texture Refining
Improvement in the appearance of skin
X
Complex
smoothness (visual)
Improvements in skin texture/smoothness
X
(tactile)
Improvement in overall appearance of skin
X
quality (visual)
Pore Minimizing
Improvement in Pore Size Appearance
X
Complex
Improvement in Appearance of Shine
X
Improvement in Overall Skin Appearance
X
Visible Redness
Improvement in Skin Redness/Red Patches
X
Neutralizing
Improvement in Overall Skin Appearance
X
Complex
“X” indicates statistically significant improvement at later time point when compared to baseline (p < 0.05)
Consumer home-use testing was carried out on all formula combinations consisting of the base oil mixed with two different targeted booster complexes. The objective of these studies was to evaluate consumer perception of the various attributes of the oil products immediately following initial usage, and after two and four weeks of use. Results indicate that the oil products are well appreciated by the consumer both aesthetically and in perceived efficacy.
While the invention has been described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims.
1.PublishNumber: US-2017281492-A1
2.Date Publish: 20171005
3.Inventor: DERSH JUSTIN
GENESKY Geoffrey
GOLDBERG JODI
ROBERT VALERIE
FU Victoria
ELMASRY CAROL
4.Inventor Harmonized: DERSH JUSTIN(US)
GENESKY Geoffrey(US)
GOLDBERG JODI(US)
ROBERT VALERIE(US)
FU Victoria(US)
ELMASRY CAROL(US)
5.Country: US
6.Claims:
(en)An oil base skin care composition including squalane and a method for treating skin are disclosed. The method includes the step of individually displaying a plurality of visual skin guides to a consumer. Each of the visual skin guides includes a plurality of visual representations of a categorical skin condition. Each of the visual representations correspond to a severity score for the categorical skin condition on the visual skin guide. The method further includes correlating the severity score for each of the categorical skin conditions for each of the visual skin guides to the consumer's current skin condition. At least two target skin conditions from the plurality of categorical skin conditions are determined in response to the severity scores for each of the categorical skin conditions. At least one booster containing at least one active ingredient is correlated for treating each target skin condition.
7.Description:
(en)CROSS-REFERENCE TO RELATED APPLICATIONS
This patent application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/316,334 filed on Mar. 31, 2016 and entitled “Method and Composition for Treating Skin Conditions”, the disclosure of which is hereby incorporated by reference herein in its entirety and made part of the present U.S. utility patent application for all purposes.
FIELD OF THE INVENTION
The present invention is directed to a skin care composition and a method for treating skin conditions. More specifically, the present invention is directed to a skin care composition that has targeted active ingredients for treating target skin conditions and methods for creating customized skin care compositions.
BACKGROUND OF THE INVENTION
Personalized skin care systems are desirable for consumers to provide a skin care composition that meets the skin care needs of the individual consumer.
Known personalized product lines include MaCrèmeSurMesure by Dr. Pierre Ricaud, Codage Paris, Customized TCM by Yue Sai, and prescription personalized serums (Re-Plasty) by Helena Rubinstein.
Helena Rubinstein uses a skinprofiler, a cutaneous analysis device that generates quantitative data to analyze a variety of skin attributes to diagnose consumers in-store and provide them with a personalized prescription product consisting of one universal serum base and single dose of concentrate. Helena Rubenstein products only consist of one single dose of concentrate containing actives that seek to address all skincare needs. In addition, the Helena Rubenstein product is a serum (aqueous based) product with water-soluble actives. The Helena Rubinstein skinprofiler measures elasticity, pigmentation, and texture of the skin and prescribes concentrate based on these results only.
Codage Paris has a custom-made skincare product line. Consumers use a website diagnostic tool in which they answer 23 questions that were developed by different specialists (including dermatologists, pharmacists, and nutritionists). Based on the results, Codage selects and formulates a composition in their existing line and sends consumers a final product within a week. The Codage Paris system does not include a base composition with personalized boosters. Codage Paris is a serum (aqueous based) product with water soluble actives. A diagnostic tool utilized for Codage is an online survey which automatically ‘prescribes’ a final product based on provided answers. The Codage Product provides a final pre-prepared formula for the consumer, which is sent directly from store to consumer, wherein no mixing is required.
MaCrèmeSurMesure by Dr. Pierre Ricaud similarly uses an online diagnostic tool in which consumers are given a questionnaire on their current skin and lifestyle. Based on the answers they provide, the website provides them with a cream base and combination of three active concentrates. Each “concentrate” for the MaCrèmeSurMesure only contains a single active ingredient. Typical “concentrates” for the MaCrèmeSurMesure products consist solely of pure extracts (100% active extract of chufa tubers, for example) and do not provide formulations. The MaCrèmeSurMesure product is aqueous based (water based moisturizing gel texture) and booster “concentrates” are water soluble extracts in aqueous form. The consumer is sent a kit with their products and mixes at home with a small mixing tool provided, which is not easily co-soluble. MaCrèmeSurMesure uses an online questionnaire to diagnose consumer.
Yue Sai is a Customized TCM Beauty Solution Ultimate Refining Serum that includes in-store formulations in China. The tailoring of the formulations were limited and included only aqueous based compositions.
There remains a need to provide an effective, targeted anhydrous oil based skin care composition and method for treating skin that is customized to specific, individual customer target skin compositions and is readily dispersible.
BRIEF SUMMARY OF THE INVENTION
In an exemplary embodiment, a method for treating skin including the step of individually displaying a plurality of visual skin guides to a consumer. Each of the visual skin guides includes a plurality of visual representations of a categorical skin condition. Each of the visual representations correspond to a severity score for the categorical skin condition on the visual skin guide. The method further includes correlating the severity score for each of the categorical skin conditions for each of the visual skin guides to the consumer's current skin condition. At least two target skin conditions from the plurality of categorical skin conditions are determined in response to the severity scores for each of the categorical skin conditions. At least one booster containing at least one active ingredient for treating is correlated to each target skin condition In addition, an oil base formulation including squalane is provided. The booster compositions and oil base formulations are individually packaged and the booster compositions are readily dispersible in the oil base formulation.
In another exemplary embodiment, a skin care system having a base oil composition including squalane and a plurality of booster compositions readily dispersible into the base oil composition and comprising corresponding active ingredients. The corresponding active ingredients being ingredients that correspond to treatment skin conditions determined by a consumer. The system includes packaging comprising separate containers for each of the booster compositions and the base oil composition.
The present disclosure is also directed to a method for cosmetic treatment of skin by applying the above-disclosed composition onto a surface of the skin.
Other features and advantages of the present invention will be apparent from the following more detailed description of the preferred embodiment which illustrates, by way of example, the principles of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a method, according to an embodiment of the present disclosure.
FIG. 2 is a visual skin guide, according to an embodiment of the present disclosure.
FIG. 3 is a skin care system, according to an embodiment of the present disclosure.
Wherever possible, the same reference numbers will be used throughout the drawings to represent the same parts.
DETAILED DESCRIPTION OF THE INVENTION
All numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term “about”, unless otherwise indicated.
“Keratinous tissue,” as used herein, includes, but is not limited to, skin, hair, and nails.
“Homogenous” means having the visual appearance of being substantially uniform throughout, i.e., visually appears as a single phase.
The method and system, according to the present disclosure, includes a method wherein a comprehensive assisted in-store target skin condition diagnosis practice with a targeted and efficacious product that is mixed at the consumer's home in order to use. An assisted or unassisted skin diagnosis/questionnaire, using visual aids, is completed to provide targeted skin care system to address the individual customer's needs. In one embodiment, consumers are shown representative photos of common skin conditions, wherein the consumers view the visual aids and correlate the visual aids with their individual skin care needs. Based on the correlation to the target skin conditions, the consumers get a customized skin care system having a base oil composition and two selected active booster compositions, which the consumer mixes at home.
Method
FIG. 1 shows a method 100 , according to the present disclosure. Method 100 includes individually displaying a plurality of visual skin guides 200 to a consumer (step 101 ). FIG. 2 shows an exemplary visual skin guide for skin wrinkles. Although FIG. 2 shows an example of visual skin guide, the present invention is not so limited and may include other types of visual displays or other categorical skin conditions. Other suitable types of visual displays include, but are not limited to, books, brochures and pamphlets including, but not limited to, pictures and/or description of skin condition and scale, clinical pictures, and photos taken with instrumental devices. The pictures and/or photos may include representations of skin conditions for panelists of different ethnicities and skin types. The visual display will correspond to the varying ethnicities and skin types. A selection of a specific visual display is made to consumer's ethnicity and/or skin types. The visual skin guide 200 is a device including visual representations 201 , including, but not limited to, images, pictorial representations or similar visual devices that provide information regarding categorical skin conditions. In one embodiment, as shown in FIG. 2 , each of the visual skin guides includes a plurality of visual representations of a categorical skin condition. In this embodiment, each of the visual representations correspond to a severity score 203 for the categorical skin condition on the visual skin guide. The method includes determining the severity score 203 from the visual skin guides 200 , (step 103 ). For example, the visual representations may include photographs showing a particular category of skin condition of the categorical skin conditions including, but not limited to, skin brightness, skin lines/wrinkles, visibility of pores, skin texture, skin redness, skin firmness, skin tone evenness with a score that corresponds to severity. The severity score 203 may be a numerical value, grade value or any other suitable scoring that permits the comparison of the categorical skin conditions. In one embodiment, the visual skin guide 200 includes four photographs of a particular skin condition scored numerically, for example, from 1 to 3 or from 1 to 4 or from 1 to 5 or from 1 to 10 or from 1 to 20 or from 1 to 100.
The method 100 further includes correlating the severity score 203 for each of the categorical skin conditions for each of the visual skin guides to the consumer's current skin condition. The correlating includes comparing the severity scores of each of the categorical skin conditions and determining a plurality of target skin conditions for treatment (step 105 ). The correlation may include a comparison of the numerical value, grade or other value indicator for the severity of the skin condition to determine which skin conditions are suitable for treatment. In other embodiments, the correlation may include a consultation with a skin care professional, who may assist the consumer in determining the severity score or may assist in comparing the severity score in determining the target skin conditions. At least two target skin conditions are determined from the plurality of categorical skin conditions in response to the severity scores for each of the categorical skin conditions with or without consultation with a skin care professional.
In the embodiment, wherein consultation from a skin care professional is utilized, consultation time of about 20 minutes with consumer has been determined to be beneficial. The skin care consultant may provide direction relating to the consumer's current regimen, skin type, skin concerns and lifestyle. To assess top skin concerns, diagnostic tools which may include, but is not limited to, a combination of a special prescription card (ranking of concerns) and reference pictures (skin atlas) are utilized.
As shown in FIG. 1 , after the target skin conditions are determined, boosters with at least one active ingredient are correlated for each of the target skin conditions (step 107 ). The boosters that are selected for the target skin conditions are selected based upon active ingredients that provide improvement in the target skin condition. For example, in one embodiment, the boosters containing active ingredients correlating to target conditions are selected as compositions that are capable of treating conditions selected from skin brightness, skin wrinkles, visibility of pores, skin texture, skin redness, skin firmness, and skin tone evenness. After the boosters are selected, a kit including the selected booster and base oil are created or assembled (step 109 ).
Brightening Booster Composition
In one embodiment, the target skin condition determined for treatment is skin brightness. The active ingredient corresponding to skin brightness includes one or more actives that provide improvement to skin brightness. In one embodiment, at least 25% or from about 25% to about 40% or from about 28% to about 35%, about 26%, about 30%, about 34%, or about 38%, by weight of the brightening booster active for skin brightness is included in the brightening booster composition. For example, in one embodiment, the actives corresponding to the skin brightness include one or more of ascorbyl tetraisopalmitate, phenylethyl resorcinol, arbutin, eperua falcata bark extract, ceramides, punica granatum fruit extract, citrus aurantium dulcis (orange) peel essential oil, rapeseed oil, cassia alata leaf extract, purple rice extract, other components that provide improvement to skin brightness, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to skin brightness include greater than about 27% or from about 28% to about 34% or from about 29% to 31%, about 28%, about 30%, about 32%, or about 34% by weight of the brightening booster composition ascorbyl tetraisopalmitate, and greater than about 1% or from about 1% to about 5% or from about 2% to 3.5%, about 1%, about 2%, about 3%, or about 4%, by weight of the brightening booster composition phenylethyl resorcinol.
Pore Minimizing Booster Composition
In one embodiment, the target skin condition determined for treatment is visibility of pores. The active ingredient corresponding to skin brightness includes one or more actives that provide improvement to visibility of pores. In one embodiment, at least 25% or from about 25% to about 40% or from about 28% to about 35%, about 25%, about 28%, about 31%, about 33%, about 36% or about 39% by weight of the pore minimizing active for pore minimizing is included in the brightening booster composition. For example, in one embodiment, the actives corresponding to the visibility of pores include one or more of ascorbyl tetraisopalmitate, salicylic acid, crithimum maritimum extract, totarol, ulkenia amoeboidea oil, other components that provide improvement to visibility of pores, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to visibility of pores include greater than about 27% or from about 28% to about 34% or from about 29% to 31%, about 28%, about 30%, about 32%, or about 34% by weight of the pore minimizing booster composition ascorbyl tetraisopalmitate, greater than about 0.5% or from about 0.75% to about 2.0% or from about 1.0% to 1.5%, about 1.1%, about 1.2%, about 1.3%, or about 1.4% by weight of the pore minimizing booster composition salicylic acid, and greater than about 0.25% or from about 0.05% to about 0.25% or from about 0.07% to 0.15% or about 0.10%, about 0.11%, about 0.13%, or about 0.14% by weight of the pore minimizing booster composition about crithimum maritimum extract, based upon the weight of the booster composition.
Texture Refining Booster Composition
In one embodiment, the target skin condition determined for treatment is texture refining. The active ingredient corresponding to texture refining includes one or more actives that provide improvement to skin texture. In one embodiment, the active ingredients in the booster composition corresponding to texture refining include greater than about 7.5% or from about 10% to about 20% or from about 11% to about 14%, about 10%, about 12%, about 14%, about 16%, about 18%, or about 20% by weight of the texture refining booster composition. For example, in one embodiment, the actives corresponding to skin texture include one or more of glyceryl linoleate (and) glyceryl oleate (and) glyceryl linolenate, punica granatum fruit extract, shea butter, rice bran oil, safflower oil, phospholipids, panax ginseng root extract, other components that provide improvement to skin texture, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to skin texture include greater than about 7.5% or from about 10% to about 20% or from about 11% to about 14%, about 10%, about 12%, about 14%, about 16%, about 18% or about 20% by weight of the texture refining booster composition glyceryl linoleate (and) glyceryl oleate (and) glyceryl linolenate.
Visible Redness Booster Composition
In one embodiment, the target skin condition determined for treatment is visible redness. The active ingredient corresponding to visible redness includes one or more actives that provide improvement to the skin redness. In one embodiment, the active ingredients in the booster composition corresponding to visible redness include greater than about 7.5% or from about 10% to about 20% or from about 11% to 14%, about 10%, about 12%, about 14%, about 16%, about 18% or about 20% by weight of the visible redness booster composition. For example, in one embodiment, the actives corresponding to the skin texture include one or more of helianthus annuus (sunflower) seed oil unsaponifiables, melissa officinalis leaf oil, zingiber officinale (ginger) root oil, anthemis nobilis flower oil, other components that provide improvement to skin redness, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to skin redness include at least one active ingredient corresponding to skin redness include greater than about 7.5% or from about 10% to about 20% or from about 11% to 14%, about 12%, about 14%, about 16%, about 18%, or about 20% by weight of the visible redness booster composition helianthus annuus (sunflower) seed oil unsaponifiables, based upon the weight of the booster composition.
Wrinkle Reducing Booster Composition
In one embodiment, the target skin condition determined for treatment is skin wrinkles. The active ingredient corresponding to wrinkle reducing includes one or more actives that provide improvement to the skin wrinkles. For example, in one embodiment, the actives corresponding to the skin wrinkles include at least one active ingredient selected from the group consisting of retinol, retinyl palmitate, punica granatum fruit extract, pelargonium graveolens flower oil, melissa officinalis leaf oil, zingiber officinale (ginger) root oil, theobroma cacao (cocoa) extract, purple rice extract, phytosphingosine, cinnamic acid, other components that provide improvement to skin wrinkles, any other suitable soluble/dispersible targeted active ingredient, and combinations thereof. In one embodiment, the active ingredients in the booster composition corresponding to wrinkle reduction include greater than about 0.5% or from about 1.0% to about 3.0% or from about 1.5% to 2.0%, about 1.0%, about 1.5%, about 2.0%, about 2.5%, or about 3.0% by weight of the wrinkle reducing booster composition. In one embodiment, the active ingredients in the booster composition corresponding to skin wrinkles include at least one active ingredient corresponding to skin wrinkles include greater than about 0.25% or from about 0.5% to about 1.5% or from about 0.75% to 1.00% about 0.5%, about 0.7%, about 0.9%, about 1.1%, about 1.3% or about 1.5% by weight of the wrinkle reducing booster composition retinol, and greater than about 0.25% or from about 0.5% to about 1.5% or from about 0.75% to 1.00%, about 0.5%, about 0.7%, about 0.9%, about 1.1%, about 1.3% or about 1.5%, by weight of the wrinkle reducing booster composition retinyl palmitate, based upon the weight of the booster composition.
Booster Additives
The booster compositions noted above may further include additional additives. For example, the booster compositions may include essential oils, Vitamin E, emollients or other ingredients for skin enhancement, solubilization or other beneficial or efficacious purpose. In one embodiment, for example, the booster compositions may include squalane for moisturization, capryloyl salicylic acid for cell turnover and/or botanical oils for skin conditioning.
Base Oil Composition
In addition to the plurality of booster compositions, a base oil composition is also provided. Each of the base oil and the booster compositions are formulated with an anhydrous oil composition, wherein the composition is preferably devoid of water and water based components. The anhydrous composition is appropriate for custom, tailored skin care kit as the compositions contain no water and therefore less prone to microbiological contamination. The anhydrous oil based base oil composition and booster compositions provide a high affinity to skin due to the oil base and permit beneficial mixing of the desired actives. The base oil includes components suitable for providing skin care benefits, such as moisturization, protection of skin barrier, or other skin benefit. Squalane or botanical oils, for example, in a concentration comprising greater than about 20% or greater than about 25% or greater than about 30% or greater than about 35%, by weight of total composition. In one embodiment, the base oil composition comprises squalane, botanical oil, hexyldecanol, and tocopherol, octyldodecanol, dicaprylyl ether, zea mays (corn) oil, passiflora edulis seed oil, and/or oryza sativa (rice) bran oil. Booster composition and base oil composition are formulated cosoluble for ease of use.
Cosolubilization
The booster compositions described above include the active ingredients noted specifically for the categorical skin condition (e.g., skin brightness, skin wrinkles, visibility of pores, skin texture, and/or skin redness). In addition, the compositions cosolubilize to permit easy dispersion of the booster composition into the base oil composition. In addition to easy dispersion, the system according to the present disclosure ensures rapid homogeneity of the final products after combination of booster and base components by the consumer. In each of the booster compositions, at least one of the ingredients in the base oil composition are included in the booster compositions. For example, in one embodiment, squalane is included in each of the booster compositions. In one particularly advantageous embodiment, greater than about 20% or greater than about 25% or greater than about 30% or greater than about 35%, by weight of total composition squalane is included in each of the booster compositions. Visual assessment may be conducted to ensure cosolubility. For example, cosolubility may be determined by visual determination of incompatibility, immicible components, precipitates or other visual indicators indicating a lack of cosolubility.
Auxiliaries
The composition, according to the invention, may comprise at least one dyestuff chosen especially from pigments, nacres, liposoluble dyes, and mixtures thereof.
The term “pigments” should be understood as meaning white or colored, mineral or organic particles of any shape, which are insoluble in the physiological medium and are intended to color the composition.
The term “nacres” should be understood as meaning iridescent particles of any shape, especially produced by certain molluscs in their shell or else synthesized.
The term “dyes” should be understood as meaning generally organic compounds that are soluble in fatty substances, such as oils.
The pigments may be white or colored, and mineral and/or organic. Among the mineral pigments that may be mentioned are titanium dioxides, optionally surface-treated, zirconium oxide and cerium oxide, and also zinc oxide, iron oxide (black, yellow or red) or chromium oxide, manganese violet, ultramarine blue, chromium hydrate and ferric blue and metal powders, such as aluminum powder or copper powder.
An example that may be mentioned is micronized titanium dioxide powder surface-treated with a silica/aluminum hydroxide/alginic acid mixture, sold under the name MT-100AQ.
Among the organic pigments that may be mentioned are carbon black, pigments of D&C type and lakes based on cochineal carmine or on barium, strontium, calcium or aluminum.
The nacreous pigments may be chosen from white nacreous pigments, such as mica coated with titanium or with bismuth oxychloride, colored nacreous pigments, such as titanium mica coated with iron oxides, titanium mica coated especially with ferric blue or with chromium oxide, titanium mica coated with an organic pigment of the abovementioned type, and also nacreous pigments based on bismuth oxychloride.
The liposoluble dyes are, for example, Sudan red, D&C Red No. 17, D&C Green No. 6, β-carotene, soybean oil, Sudan brown, D&C Yellow No. 11, D&C Violet No. 2, D&C Orange No. 5, quinoline yellow, annatto and bromo acids.
The dyestuffs may be present in an amount of from about 0.01% to about 30%, by weight, such as from about 0.1% to about 20%, by weight, such as from about 0.5% to about 15%, by weight, and most preferably from about 0.5% to about 5%, by weight, relative to the total weight of the composition.
In a known manner, the composition of the invention may also contain adjuvants that are common in cosmetics, such as humectants, preserving agents, antioxidants, complexing agents, solvents, fragrances, bactericides, odor absorbers, vitamins, moisturizers, self-tanning compounds and anti-wrinkle active agents. The amounts of these various adjuvants are those conventionally used in the field under consideration, for example, from 0.01% to 20% of the total weight of the composition. Depending on their nature, these adjuvants may be introduced into the fatty phase and/or into lipid vesicles. In one embodiment, the additives or adjuvants would be added to the booster formulations to functionalize them for specific targeted treatments/needs.
The composition of the present disclosure may also contain cosmetically acceptable additives or adjuvants as well as cosmetic or dermatologic active agents. Representative additives and adjuvants include, for example, oil-soluble or oil-miscible solvents or co-solvents. Suitable examples of additives and adjuvants include, but are not limited to, fatty alcohols, fatty amides, alkylene carbonates, glycols, lower alcohols (e.g. ethanol, propanediol), dispersion enhancing agents, polymers, thickening agents, stabilizers, moisturizers, humectants, colorants, fillers, chelating agents, antioxidants (e.g. BHT, tocopherol), essential oils, fragrances, dyes, neutralizing or pH-adjusting agents (e.g., citric acid, triethylamine (TEA) and sodium hydroxide), preservatives, bactericides, conditioning or softening agents (e.g., panthenol and allantoin), extracts, such as botanical extracts, or any other ingredient commonly used in cosmetics for this type of application. Additives and adjuvants may be present in the compositions in amounts generally ranging from about 0.01% to about 10%, by weight. Examples of cosmetic active agents or dermatological active agents include free-radical scavengers, vitamins (e.g., Vitamin E and derivatives thereof), anti-elastase and anti-collagenase agents, peptides, fatty acid derivatives, steroids, trace elements, extracts of algae and of planktons, enzymes and coenzymes, flavonoids and ceramides, hydroxy acids and mixtures thereof, and enhancing agents. These ingredients may be soluble or dispersible in oil phase(s) that is/are present in the composition.
Of course, a person skilled in the art will take care to choose this or these optional additional compounds so that the advantageous properties intrinsically attached to the composition, in accordance with the invention, are not, or not substantially, detrimentally affected by the envisaged addition or additions.
Needless to say, a person skilled in the art will take care to select this or of these optional additional compound(s), and/or the amount thereof, such that the advantageous properties of the composition, according to the invention, are not, or are not substantially, adversely affected by the envisaged addition.
Packaging
As shown in FIG. 1 , after the booster compositions are determined and the base oil composition is provided, the booster compositions and oil base formulations are individually assembled into a kit or system including the selected boosters and base oil (step 109 ). FIG. 3 shows an exemplary configuration of a skin care system 300 , according to an embodiment of the present disclosure. The packaging and system are configured to permit mixing of the booster compositions 303 and the base oil composition 301 at home with simple agitation. For example, the base oil composition 301 includes sufficient space in the packaging to receive the booster composition 303 and to permit agitation, such as by shaking the container. Ophthalmic tip tubes, for example, may help consumer mix boosters into primary dropper containing base. The co-solubilized booster composition 303 readily disperses into the base oil composition to form a treatment composition.
The following examples are intended to further illustrate the present invention. They are not intended to limit the invention in any way. Unless otherwise indicated, all parts are by weight.
EXAMPLES
Example 1
TABLE 1
INGREDIENT
Base Oil
EMOLLIENTS
44
SQUALANE
35
BOTANICAL OILS
20
ANTIOXIDANTS
1
Total
100
TABLE 2
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
0.6
0.6
0.6
1.2
ACID
PHENYLETHYL
3
RESORCINOL
ESSENTIAL OILS
0.7
1.2
1.2
0.6
EMOLLIENTS
32.2
9.2
8
30.2
32
SQUALANE
35
35
35
35
35
BOTANICAL OILS
20
20
20
20
20
SALICYLIC ACID
1.2
CRITHMUM MARITIMUM
3
EXTRACT*
HELIANTHUS ANNUUS
12
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
12
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
1
1
1
1
1
RETINYL PALMITATE (and)
1.5
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
9
ASCORBYL
30
30
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Example 1 shows various range of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 1 shows effective composition of base oil. TABLE 2 shows effective composition of boosters. The inventive examples in TABLE 1 and 2 show various ranges of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
Comparative Example 1
TABLE 3
INGREDIENT
Base Oil
EMOLLIENTS
89.9
SQUALANE
5
BOTANICAL OILS
5
ANTIOXIDANTS
0.1
Total
100
TABLE 4
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
5
5
5
10
ACID
PHENYLETHYL
0.1
RESORCINOL
ESSENTIAL OILS
0.1
0.1
0.1
0.1
EMOLLIENTS
84.6
79.7
54.8
78.8
88.9
SQUALANE
5
5
5
5
5
BOTANICAL OILS
5
5
5
5
5
SALICYLIC ACID
5
CRITHMUM MARITIMUM
10
EXTRACT*
HELIANTHUS ANNUUS
1
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
1
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
0.1
0.1
0.1
0.1
0.1
RETINYL PALMITATE (and)
0.1
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
0.1
ASCORBYL
5
5
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Comparative Example 1 shows various range of compositions that would not be effective For example, deficiencies of this comparative example include compositions with active levels that are beyond the solubility limit of the formulation as well as active levels that are so low that they do not provide efficacious results to the consumer.
Example 2
TABLE 5
INGREDIENT
Base Oil
EMOLLIENTS
48
SQUALANE
25
BOTANICAL OILS
25
ANTIOXIDANTS
2
Total
100
TABLE 6
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
1
1
1
1.5
ACID
PHENYLETHYL
5
RESORCINOL
ESSENTIAL OILS
1.1
1
0.9
0.5
EMOLLIENTS
30
13
10.1
26
28
SQUALANE
25
25
25
25
25
BOTANICAL OILS
25
25
25
25
25
SALICYLIC ACID
0.75
CRITHMUM MARITIMUM
1.25
EXTRACT*
HELIANTHUS ANNUUS
20
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
20
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
2
2
2
2
2
RETINYL PALMITATE (and)
0.9
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
15
ASCORBYL
28
34
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Example 2 shows various range of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 5 shows effective composition of base oil. TABLE 6 shows effective composition of boosters. The inventive examples in TABLE 5 and 6 show various ranges of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
Example 3
TABLE 7
INGREDIENT
Base Oil
EMOLLIENTS
49
SQUALANE
20
BOTANICAL OILS
30
ANTIOXIDANTS
1
Total
100
TABLE 8
Visible
Wrinkle
Pore
Texture
Redness
Reducing
Brightening
Minimizing
Refining
Neutralizing
INGREDIENT
Booster
Booster
Booster
Booster
Booster
CAPRYLOYL SALICYLIC
0.5
0.5
0.5
1
ACID
PHENYLETHYL
1
RESORCINOL
ESSENTIAL OILS
0.5
0.8
1.4
0.9
EMOLLIENTS
40.3
12.7
10.85
37.1
39
SQUALANE
20
20
20
20
20
BOTANICAL OILS
30
30
30
30
30
SALICYLIC ACID
2
CRITHMUM MARITIMUM
6.25
EXTRACT*
HELIANTHUS ANNUUS
10
(SUNFLOWER) SEED OIL
UNSAPONIFIABLES
GLYCERYL LINOLEATE
10
(and) GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
1
1
1
1
1
RETINYL PALMITATE (and)
2.7
HELIANTHUS ANNUUS
(SUNFLOWER) SEED OIL**
RETINOL***
5
ASCORBYL
34
28
TETRAISOPALMITATE
Total
100
100
100
100
100
*Includes 4% Active Crithimum Maritimum Extract
**Include 55% Active Retinyl Palmitate
***Includes 10% Active Retinol
Example 3 shows various range of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 7 shows effective composition of base oil. TABLE 8 shows effective composition of boosters. The inventive examples in TABLE 7 and 8 show various ranges of compositions which allow for solubility of high levels of actives in the boosters and allow for good co-solubility of base and boosters.
TABLE 9
INCI US
Loading (wt %)
Salicylic Acid
3%
5%*
10%*
15%*
Caprylyl Salicylic Acid
3%
5%*
10%*
15%*
Phenylethyl Resorcinol
5%
10%
15%
—
Ascorbyl Tetraisopalmitate
40%
50%
60%
—
Crithmum Martimum Extract (4% Active)
5%
10%*
15%*
—
Retinol (10% Active)
10%
20%
30%
—
Retinyl Palmitate (and) Helianthus Annuus Seed
5%
10%
20%
—
Oil (55% Active)
Glyceryl Linoleate (and) Glyceryl Oleate (and)
15%
20%
40%
—
Glyceryl Linolenate
*Insoluble
TABLE 9 shows solubility of active ingredients in base oil composition.
TABLE 10
Base with
Base with
Wrinkle
Base with
Visible Redness
Reducing
Pore and
Neutralizing
and
Texture
Booster and
Brightening
Booster
Texture
Booster from
from
Booster
INGREDIENT
Example 1
Example 2
from Example 3
CAPRYLOYL
0.2
0.42
0.17
SALICYLIC ACID
PHENYLETHYL
0.5
RESORCINOL
ESSENTIAL OILS
0.32
0.23
0.15
EMOLLIENTS
36.23
38.00
45.34
SQUALANE
35
25
20
BOTANICAL OILS
20
25
30
SALICYLIC ACID
0.13
CRITHMUM
0.21
MARITIMUM
EXTRACT*
HELIANTHUS
1.67
ANNUUS
(SUNFLOWER) SEED
OIL
UNSAPONIFIABLES
GLYCERYL
3.34
1.67
LINOLEATE (and)
GLYCERYL OLEATE
(and) GLYCERYL
LINOLENATE
ANTIOXIDANTS
1
2
1
RETINYL PALMITATE
0.25
(and) HELIANTHUS
ANNUUS
(SUNFLOWER) SEED
OIL**
RETINOL***
1.50
ASCORBYL
5.00
5.67
TETRAISOPALMITATE
Total
100
100
TABLE 10 shows an exemplary chart of booster+base combinations.
Summary of Clinical/Consumer testing:
An instrumental evaluation of the effectiveness in improving skin hydration and maintaining skin barrier function was carried out on the base oil formulation. Under the conditions of the study, the oil elicited statistically significant improvements in skin barrier function when compared to the baseline and statistically significant improvements in skin hydration when compared to the baseline.
TABLE 11
Skin Strengthening Concentrate-Clinical Instrumental Testing
Claim
Assessment
Improvement in skin barrier function (TEWL)
X
Improvement in skin hydration
X
“X” indicates statistically significant improvement at later time point when compared to baseline (p < 0.05)
Clinical evaluations were conducted on representative formulas containing each booster; formula compositions consisted of the base oil and the booster complex in the ratio 5:1. Various skin attributes of the representative formulas were evaluated via by an expert grader both initially and at later time points. Under the conditions of the study, results show a statistically significant improvement in attributes of the skin over time vs. baseline for all booster representative formulas.
TABLE 12
Attribute
Assessment
Brightening
Improvement in skin radiance/brightness/
X
Complex
luminosity
Improvement in skin tone evenness
X
Improvement in overall appearance of skin
X
quality
Wrinkle Reducing
Improvement in appearance of Fine Lines
X
Complex
Improvement in appearance of Wrinkles
X
Improvement in Overall Appearance of Skin
X
Quality
Texture Refining
Improvement in the appearance of skin
X
Complex
smoothness (visual)
Improvements in skin texture/smoothness
X
(tactile)
Improvement in overall appearance of skin
X
quality (visual)
Pore Minimizing
Improvement in Pore Size Appearance
X
Complex
Improvement in Appearance of Shine
X
Improvement in Overall Skin Appearance
X
Visible Redness
Improvement in Skin Redness/Red Patches
X
Neutralizing
Improvement in Overall Skin Appearance
X
Complex
“X” indicates statistically significant improvement at later time point when compared to baseline (p < 0.05)
Consumer home-use testing was carried out on all formula combinations consisting of the base oil mixed with two different targeted booster complexes. The objective of these studies was to evaluate consumer perception of the various attributes of the oil products immediately following initial usage, and after two and four weeks of use. Results indicate that the oil products are well appreciated by the consumer both aesthetically and in perceived efficacy.
While the invention has been described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims.
You are contracting for Method and composition for treating skin conditions
Expert Method and composition for treating skin conditions
You are commenting for Method and composition for treating skin conditions